Publications by authors named "S Idell"

Article Synopsis
  • Bleeding in the pleural space can lead to retained hemothorax (RH), causing lung issues and shortness of breath due to clot formation.
  • Researchers tested single-chain urokinase (scuPA) for intrapleural clot dissolution in a rabbit model, comparing its effectiveness against another agent, single-chain tissue plasminogen activator (sctPA).
  • Results indicated that delivering two doses of scuPA was more effective than a single higher dose, and both agents were equally capable of clearing clots and promoting fluid drainage, though more clinical trials are needed to determine the best treatment approach.
View Article and Find Full Text PDF

During the progression of pleural fibrosis, pleural mesothelial cells (PMCs) undergo a phenotype switching process known as mesothelial-mesenchymal transition (MesoMT). During MesoMT, transformed PMCs become myofibroblasts that produce increased extracellular matrix (ECM) proteins, including collagen and fibronectin (FN1) that is critical to develop fibrosis. Here, we studied the mechanism that regulates FN1 expression in myofibroblasts derived from human pleural mesothelial cells (HPMCs).

View Article and Find Full Text PDF

During the development of pleural fibrosis, pleural mesothelial cells (PMCs) undergo phenotypic switching from differentiated mesothelial cells to mesenchymal cells (MesoMT). Here, we investigated how external stimuli such as TGF-β induce HPMC-derived myofibroblast differentiation to facilitate the development of pleural fibrosis. TGF-β significantly increased di-phosphorylation but not mono-phosphorylation of myosin II regulatory light chain (RLC) in HPMCs.

View Article and Find Full Text PDF

Retained hemothorax (RH) is a commonly encountered and potentially severe complication of intrapleural bleeding that can organize with lung restriction. Early surgical intervention and intrapleural fibrinolytic therapy have been advocated. However, the lack of a reliable, cost-effective model amenable to interventional testing has hampered our understanding of the role of pharmacological interventions in RH management.

View Article and Find Full Text PDF

The pathology of atherosclerosis, a leading cause of mortality in patients with cardiovascular disease, involves inflammatory phenotypic changes in vascular endothelial cells. This study explored the role of the dedicator of cytokinesis (DOCK)-2 protein in atherosclerosis. Mice with deficiencies in low-density lipoprotein receptor and Dock2 (LdlrDock2) and controls (Ldlr) were fed a high-fat diet (HFD) to induce atherosclerosis.

View Article and Find Full Text PDF